Ophthalmic Devices Market Report 2026

Ophthalmic Devices Market Overview

• Ophthalmic Devices market size has reached to $47.31 billion in 2025 • Expected to grow to $70.19 billion in 2030 at a compound annual growth rate (CAGR) of 8.3% • Growth Driver: The Impact Of Increasing Incidence And Prevalence Of Eye Diseases On The Ophthalmic Devices Market • Market Trend: Advancing Ophthalmic Devices For Enhanced Patient Care And Outcomes • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Ophthalmic Devices Market?

Ophthalmology is a branch of medicine that focuses on the diagnosis, treatment, and prevention of diseases and disorders related to the eyes and visual system. Ophthalmic devices are used in the diagnosis and treatment of eye-related diseases. Ophthalmologists are medical doctors who specialize in eye care, including performing eye exams, prescribing corrective lenses, diagnosing eye conditions, and performing surgeries. The main types of ophthalmic devices are vision care devices and equipment, cataract surgery devices and equipment, refractive surgery devices and equipment, and diagnostic and monitoring ophthalmic devices and equipment. Cataract surgery devices and equipment are devices that emit ultrasound waves that soften and break up the lens so that it can be removed by suction. The type of expenditure is public and private. The products used are instruments/equipment and disposables. The various end uses involved are hospitals and clinics, diagnostic laboratories, and others.

What Is The Ophthalmic Devices Market Growth Forecast?

The ophthalmic devices market size is expected to see strong growth in the next few years. It will grow to $70.19 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to increasing demand for age-related eye disease treatments, rising adoption of AI-based ophthalmic diagnostics, expansion of outpatient eye surgery centers, growing focus on preventive eye care, increasing investments in ophthalmic technology innovation. Major trends in the forecast period include increasing adoption of advanced diagnostic ophthalmic imaging, rising use of minimally invasive eye surgery devices, growing integration of digital eye examination tools, expansion of laser-based vision correction systems, enhanced focus on early eye disease detection.

Global Ophthalmic Devices Market Segmentation

1) By Device: Vision Care Devices And Equipment, Cataract Surgery Devices And Equipment, Refractive Surgery Devices And Equipment, Diagnostic And Monitoring Ophthalmic Devices And Equipment 2) By Product: Instruments Or Equipment, Disposables 3) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users 4) By Type of Expenditure: Public, Private Subsegments: 1) By Vision Care Devices And Equipment: Eyeglasses, Contact Lenses, Low Vision Aids 2) By Cataract Surgery Devices And Equipment: Cataract Surgery Instruments, Cataract Surgery Implants (Intraocular Lenses), Cataract Surgery Devices (Phacoemulsification Systems) 3) By Refractive Surgery Devices And Equipment: LASIK Devices, SMILE Surgery Devices, PRK Surgery Devices 4) By Diagnostic And Monitoring Ophthalmic Devices And Equipment: Fundus Cameras, Optical Coherence Tomography (OCT) Scanners, Perimeters, Retinal Imaging Systems, Slit Lamps

What Is The Driver Of The Ophthalmic Devices Market?

The increasing incidence and prevalence of eye diseases are expected to contribute to the growth of the ophthalmic device market. Eye disorders such as age-related macular degeneration (AMD), glaucoma, and cataracts are becoming major causes of visual impairment and blindness globally. Ophthalmic devices play a crucial role in diagnosing, treating, and managing various eye disorders and conditions. For instance, in August 2024, according to the National Health Service, an public sector organization, in 2024, NHS-funded sight tests hit a record high of over 841,000, reflecting a 6.6% rise compared to 2023. The increasing incidence and prevalence of eye-related disorders is expected to drive the use of ophthalmic devices in the diagnosis and treatment of eye-related diseases.

Key Players In The Global Ophthalmic Devices Market

Major companies operating in the ophthalmic devices market are Luxottica Group S.p.A., Johnson & Johnson, Hoya Corporation, CooperVision AG, Bausch Health Companies Inc., Carl Zeiss AG, Flex Ltd., Nidek Co. Ltd., Topcon Corporation, Alcon Inc., EssilorLuxottica, Novartis AG, Regeneron Pharmaceuticals Inc., Roche Holding AG, Santen Pharmaceutical Co. Ltd., Rohto Pharmaceutical Co. Ltd., Menicon Co. Ltd., Chengdu Kanghong Pharmaceutical, Glaukos Corporation, STAAR Surgical Company, Omeros Corporation, Aerie Pharmaceuticals Inc., Alimera Sciences Inc., Iridex

Global Ophthalmic Devices Market Trends and Insights

Major companies operating in the ophthalmic devices market are focusing on developing innovative products to sustain their position in the market. They are investing in research and development to introduce innovative products and expand their market share. For instance, in May 2023, Sight Sciences Inc, a US-based eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, announced the development of two innovative ophthalmic systems, two of its proprietary glaucoma and dry eye technologies, the OMNI Surgical System and the TearCare System. The OMNI Surgical System technology will facilitate surgeons’ ability to perform minimally invasive, implant-free glaucoma procedures in adults with primary open-angle glaucoma. The TearCare System technology for dry eye enables an interventional eyelid procedure for diseased meibomian glands and is indicated for the application of localized heat therapy in adult patients with evaporative dry eye disease because of meibomian gland dysfunction.

What Are Latest Mergers And Acquisitions In The Ophthalmic Devices Market?

In July 2024, Bausch + Lomb, a US based eye health company, acquired Trukera Medical, a USbased diagnostic firm, to broaden its presence in the dry eye space. With this acquisition, Bausch + Lomb secured ScoutPro, a portable tear osmolarity device from Trukera, enabling better point-of-care diagnostics for ocular surface disease and dry eye. Trukera Medical is a US-based company that develops diagnostic tools for tear-film osmolarity measurement.

Regional Outlook

North America was the largest region in the global ophthalmic devices market in 2025. Asia-Pacific was the second largest region in the global ophthalmic devices market. Africa. was the smallest region in the global ophthalmic devices market. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

What Defines the Ophthalmic Devices Market?

The ophthalmic devices consist of sales of instruments such as optical coherence tomography scanners, perimeters/visual field analyzers, ophthalmic pachymeters, wavefront aberrometers, and others. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.